RAG-01 Presentation事件 Development and Clinical Progress of RAG-01, a Novel saRNA Targeting p21 for Non-Muscle Invasive Bladder Cancer Treatment (摘要) 会议:…ractigenOctober 11, 2024
事件 Therapeutic Development of saRNA for Duchenne Muscular Dystrophy by Targeted Activation of Utrophin (海报) 会议：2024…ractigenMarch 21, 2024
事件 SCAD: a platform technology for CNS delivery of duplex RNA by intrathecal administration (海报) 会议:…EnvisionNovember 2, 2023
事件 Therapeutic Development of saRNA for Duchenne Muscular Dystrophy by Targeted Activation of Utrophin (海报) 会议:…EnvisionNovember 2, 2023
RAG-01 Presentation事件 Preclinical development of RAG1-40-31L: A novel small activating RNA-lipid conjugate targeting tumor suppressor gene p21 for treatment of non-muscle invasive bladder cancer. (摘要) 会议:…EnvisionJune 7, 2023
RAG-17 Presentation事件 siRNA-ACO is a convenient phosphoramidite-based conjugate that enables RNAi in the CNS via local administration with superior efficacy in the treatment of ALS rodent models (海报) 会议:…EnvisionMay 12, 2023
RAG-17 Presentation事件 Local administration of a novel siRNA conjugate (siRNA-ACO) into the CNS extends survival and improves motor function in the SOD1G93A mouse model for ALS (海报) 会议:…EnvisionMarch 10, 2023
事件 中美瑞康首席科学官Robert Place博士在第六届中国小核酸技术与应用学术会议上发表主旨演讲 2017年10月10日至11日，第六届中国小核酸技术与应用学术会议在昆山皇冠国际会展酒店如期举行。此次会议邀请了来自学术及企业界的各路小核酸领域的专家，包括中美瑞康李龙承董事长，囊括了14场主旨报告及40场大会报告，力求推动小核酸领域的新技术、新成果向市场快速转化。…EnvisionOctober 11, 2017
